Liver News and Research

RSS

Novel transcatheter repair system for tricuspid regurgitation shows promising results at one year

Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced significant improvements in blood flow through the heart and in quality of life at one year, according to research presented at the American College of Cardiology's 71st Annual Scientific Session.

5 Apr 2022

Acute respiratory distress syndrome may increase death risk among young COVID-19 patients

A new study estimated the risk and prevalence of acute respiratory distress syndrome in hospitalized young adults with SARS-CoV-2 infection.

4 Apr 2022

Addition of alirocumab to high-intensity statin treatment reduces key measures of plaque vulnerability

Compared with a placebo, the addition of the injectable cholesterol-lowering drug alirocumab to high-intensity statin treatment in patients who have had a heart attack resulted in twofold greater reductions in three key measures of plaque vulnerability that signal risk for future cardiac events, according to research presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Experimental siRNA therapeutic shows promise to reduce an important driver of heart disease risk

While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or "bad" cholesterol, and other lipids, to date there are no approved treatments to lower lipoprotein(a), a lesser-known driver of heart disease risk.

3 Apr 2022

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Scientists discuss the pathogenic characteristics of SARS-CoV-2 and available therapeutic interventions for treating COVID-19.

3 Apr 2022

Investigational drug vupanorsen reduces non-HDL cholesterol by up to 28%

The investigational drug vupanorsen reduced total levels of non-high-density lipoprotein (non-HDL) cholesterol by up to 28% in patients with high cholesterol who were already taking a cholesterol-lowering statin medication, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Results from a preclinical study add new evidence that a multi-mineral dietary supplement known as Aquamin could be a simple and effective way to reduce the long-term health consequences of non-alcoholic fatty liver disease.

3 Apr 2022

Experimental siRNA therapy reduces a key driver of heart disease risk by up to 98%

Findings from a new Cleveland Clinic-led phase 1 trial show that an experimental "gene silencing" therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%.

3 Apr 2022

Smokers have lower odds of surviving a heart attack than non-smokers

Smokers have a lower chance of surviving a heart attack than non-smokers, according to new data compiled by researchers at Jordan University of Science and Technology in Irbid.

2 Apr 2022

Large-scale comparative study of cancer trends in China and the USA

Cancer is currently the most common cause of death in most developed countries around the world. In the USA, comprehensive progress in cancer research, prevention, and care has resulted in reduced rates of cancer since the 1990s, indicating that these strategies could also benefit other countries, such as China, where the cancer burden is steadily increasing.

31 Mar 2022

Increased levels of a microRNA in type 2 diabetes have negative effect on insulin secretion

Researchers at Lund University have discovered increased levels of of a microRNA in type 2 diabetes, which has a negative effect on insulin secretion.

29 Mar 2022

New test predicts sepsis well before blood clotting and organ failure

In a potential paradigm change for sepsis diagnostics, a new test predicted sepsis soon after infection in mice - well before blood clotting and organ failure - enabling early antibiotic treatment and markedly increased survival.

29 Mar 2022

New technology could replace conventional biopsies and histology with real-time imaging

MediSCAPE, a high-speed 3D microscope designed by Columbia Engineers, can see real-time cellular detail in living tissues to guide surgery, speed up tissue analyses, and improve treatments.

28 Mar 2022

Magneto-activated natural killer cells for treating solid tumors

Cancer immunotherapy - a type of treatment that enlists our own immune cells to attack tumors - has revolutionized the way that many types of cancer are treated. One type of immunotherapy under investigation uses natural killer cells, a type of immune cell that can seek and destroy harmful cells.

28 Mar 2022

Liver News and Research

Novel transcatheter repair system for tricuspid regurgitation shows promising results at one year

Acute respiratory distress syndrome may increase death risk among young COVID-19 patients

Addition of alirocumab to high-intensity statin treatment reduces key measures of plaque vulnerability

Experimental siRNA therapeutic shows promise to reduce an important driver of heart disease risk

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Investigational drug vupanorsen reduces non-HDL cholesterol by up to 28%

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Experimental siRNA therapy reduces a key driver of heart disease risk by up to 98%

Smokers have lower odds of surviving a heart attack than non-smokers

Large-scale comparative study of cancer trends in China and the USA

Increased levels of a microRNA in type 2 diabetes have negative effect on insulin secretion

New test predicts sepsis well before blood clotting and organ failure

New technology could replace conventional biopsies and histology with real-time imaging

Magneto-activated natural killer cells for treating solid tumors

Chaperone-mediated autophagy needed to protect against atherosclerosis

Tuberculosis infection protects mice against COVID-19

Exploring the vital connection between gut microbes, physical activity, and health

Flinders research uncovers how enteric nervous system in the gut communicates with the brain

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

Study: Liver disease negatively impacted by lifestyle changes during the pandemic

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News